Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Carboprost tromethamine

Carboprost tromethamine

pharmaceutical raw materials
Carboprost tromethamine structure

Carboprost tromethamine 

structure
  • CAS No:

    58551-69-2

  • Formula:

    C21H36O5.C4H11NO3

  • Chemical Name:

    Carboprost tromethamine

  • Synonyms:

    Prosta-5,13-dien-1-oic acid,9,11,15-trihydroxy-15-methyl-,(5Z,9α,11α,13E,15S)-,compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1);1,3-Propanediol,2-amino-2-(hydroxymethyl)-,(5Z,9α,11α,13E,15S)-9,11,15-trihydroxy-15-methylprosta-5,13-dien-1-oate (salt);Carboprost tromethamine;Prostinfenem;Hemabate;Prostodin;U 32921E;Carboprost trometamol;Carboprost tromethamine Salt;Prostin 15M

  • Categories:

    Active Pharmaceutical Ingredients  >  Hormones and the Endocrine System

Description

White or almost white powder.


Carboprost Tromethamine is the tromethamine salt of the (15S)-15 methyl analogue of naturally occurring prostaglandin F2 alpha (PGF2 alpha) with oxytocic activity. Mimicking endogenous PGF2 alpha, carboprost activates prostaglandin F receptor, a G-protein coupled receptor, on smooth muscle cells, thereby resulting in smooth muscle contractions. When administered intramuscularly on gravid subjects, this agent induces myometrium contractions, thereby initiating luteolysis and consequently parturition. Furthermore, carboprost's action on vascular smooth muscle and gastrointestinal tract sphincters leads to raised blood pressure and induces vomiting or diarrhea, respectively.

Carboprost tromethamine Basic Attributes

489.64

489.330170

U4526F86FJ

C47433

2937500000

Characteristics

184.70000

1.79410

1.153g/cm3

536.6ºC at 760 mmHg

292.4ºC

Safety Information

NONH for all modes of transport

|Danger|H335 (18.18%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]|P201, P202, P261, P271, P281, P304+P340, P308+P313, P312, P403+P233, P405, and P501|Aggregated GHS information provided by 33 companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Drug Information

Drugs that stimulate contraction of the myometrium. They are used to induce LABOR, OBSTETRIC at term, to prevent or control postpartum or postabortion hemorrhage, and to assess fetal status in high risk pregnancies. They may also be used alone or with other drugs to induce abortions (ABORTIFACIENTS). Oxytocics used clinically include the neurohypophyseal hormone OXYTOCIN and certain prostaglandins and ergot alkaloids. (From AMA Drug Evaluations, 1994, p1157) (See all compounds classified as Oxytocics.)

15-methylprostaglandin F2alpha-tromethamine

Carboprost tromethamine Use and Manufacturing

Uses

Oxytocic.

Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients

Computed Properties

Molecular Weight:489.6
Hydrogen Bond Donor Count:8
Hydrogen Bond Acceptor Count:9
Rotatable Bond Count:15
Exact Mass:489.33016746
Monoisotopic Mass:489.33016746
Topological Polar Surface Area:185
Heavy Atom Count:34
Complexity:527
Defined Atom Stereocenter Count:5
Defined Bond Stereocenter Count:2
Covalently-Bonded Unit Count:2
Compound Is Canonicalized:Yes

Drug Function and Efficacy

Not described in detail

This ingredient has been used in drugs with the following functions (note: it does not mean that the ingredient itself has the following health functions)

Related Drugs

Registered Holders

  • TIEN (TIANJIN) PHARMACEUTICAL CO LTD

    United States United States
    Active
  • MSN LABORATORIES PRIVATE LTD

    United States United States
    Active
  • EUROAPI Hungary Ltd

    United States United States
    Active

Recommended Suppliers of Carboprost tromethamine

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.